Several recent studies have recently evidenced the role of QRs in cancer cells using a GPX4 deficiency model and have highlighted the potential of ubiquinol and, therefore, QRs as novel targets for cancer treatment (Figure 2). The gene discussed is GPX4; the disease is cancer.